Status:

RECRUITING

Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?

Lead Sponsor:

Clinique Pasteur Lanroze

Conditions:

Arthroplasty Complications

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Venous thrombosis and pulmonary embolism are considered serious and potentially preventable complications of hip and knee replacement surgery. The risks of thrombosis must be weighed against the risks...

Eligibility Criteria

Inclusion

  • first line and non-traumatic total hip or knee arthroplasty
  • Patient included in an Enhanced Rehabilitation after Surgery (ERS) or "fast-track" protocol, or scheduled as an outpatient.

Exclusion

  • Patient requiring long-term anticoagulation for pre-existing co-morbidity
  • Patients with coagulation disorders (hypercoagulability)
  • Patient undergoing thrombogenic pharmacological treatment
  • History of obliterative arteriopathy of the lower limbs
  • Arterial disease
  • Obesity
  • Heart failure
  • Chronic bronchopneumopathy
  • Lymphedema
  • Chronic inflammatory disease
  • Permanent wearing of elastic restraints
  • Proximal or distal arterial bypass surgery
  • Creatinine clearance \< 15 ml/min
  • Inability to give consent
  • Revision surgery for hip or knee prosthesis
  • Metastatic cancer
  • Life expectancy less than 3 months
  • Allergy to socks or compression stockings
  • Patients presenting one or more exclusion criteria for the fast-track protocol (severe or poorly-balanced associated conditions such as diabetes or immunodepression, inability to contact the doctor or hospital department if necessary, pre-operative ASA score greater than or equal to 4).
  • Adults under guardianship or curatorship
  • Vulnerable persons in accordance with article L1121-6 of the CSP (French Public Health Code)

Key Trial Info

Start Date :

November 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 15 2026

Estimated Enrollment :

1274 Patients enrolled

Trial Details

Trial ID

NCT06563531

Start Date

November 15 2024

End Date

July 15 2026

Last Update

November 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinique Pasteur Lanroze

Brest, France, 29000